↪Trump's Order to Biden's Repeal: The Biomedical Investment Shift | 01/03/24

Set the groundwork for a significant biomedicine advancement… One that has now seen its first fruition with the FDA's landmark approval of CRISPR-based gene therapies.

Gene Editing: From Trump's EO to FDA Approval President Trump's Executive Order 13771, aimed at advancing the United States in the war for the future of medicine.  Set the groundwork for a significant biomedicine advancement…  One that has now seen its first fruition with the FDA's landmark approval of CRISPR-based gene therapies. Unveil the Potential of Gene Editing Here >> While the technology holds promise for curing numerous genetic diseases…  A political twist has arisen.  President Biden's repeal of this executive order raises questions about the future of this groundbreaking field. Understand the Impact of Policy Changes Here >> Stay informed, Simmy Adelman, Publisher Behind The Markets Note: Sometimes, colleagues of Golden Gate Marketers share special offers with us that we think our readers should be made aware of. This is one such special opportunity that we believe deserves your attention. Michael Brown, editor of GGM, wanted to share this exclusive offer with you. If you're not interested in receiving any more offers from us, please click here to unsubscribe.   221 W 9th St # Wilmington, DE 19801 It's a good idea to whitelist us to make sure you get every email. For any inquiries or concerns, please feel free to contact us. Privacy Policy Terms of Use Unsubscribe Email courtesy of FIT, LLC, owner and operator of Golden Gate Marketers. © 2021-2024 All Rights Reserved.